Fortress Biotech (NASDAQ:FBIOP) Stock Price Up 3.9% – What’s Next?

Fortress Biotech, Inc. (NASDAQ:FBIOP) shares rose 3.9% during trading on Friday . The stock traded as high as $6.74 and last traded at $6.74. Approximately 8,293 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 17,412 shares. The stock had previously closed at $6.49.

Fortress Biotech Trading Up 3.9 %

The business has a 50-day moving average of $6.44 and a 200 day moving average of $6.07.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.